enGene

enGene is a company listed under the stock ticker ENGN (CA).

Acquisition, funding and merger involving enGene.

• enGene is now listed under the stock ticker ENGN. (posted on November 3 2023).

View the org chart displaying its 14 main executives

Most searched biographies at enGene

• Jason Hanson, Chief Executive Officer (leaving)
• Wouter Joustra, Director
• Paul Hastings, Director

Popular executive movements at enGene

• Wouter Joustra has joined the company as Director  (posted on May 16 2024).
• Paul Hastings has joined the company as Director  (posted on May 16 2024).
• Raj Pruthi has joined the company as Senior Vice President, Urologic Oncology and Clinical Development  (posted on April 12 2024).

Click here to view some more movements at enGene

Create your alert
to follow the executive moves at enGene.

enGene has 2,294 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by enGene

• enGene Holdings Inc. News powered by B2i Technologies - SmartWireenGene Holdings Inc. News powered by B2i Technologies - SmartWire
• enGene - Communiqués de presse
• enGene - Press Releases

Social media about enGene

• enGene on Wikipedia, Google News & Yahoo Finance
• enGene on LinkedIn, Twitter & YouTube

Contact by email its executives including Jason Hanson

Call enGene at +1 514...

View the org chart

Register to receive your alert

Report an error